FDA-cleared device

REHOVOT, Israel, June 2, 2026 Evogene Ltd. has announced the successful completion of the first-in-human Phase 1 clinical study...

SOUTH SAN FRANCISCO, Calif., June 1, 2026 IDEAYA Biosciences and Servier have unveiled compelling results from the registrational Phase...

THOUSAND OAKS, Calif., June 1, 2026 Amgen has secured a major regulatory milestone with the European Commission approval of...

MORRISTOWN, N.J., May 21, 2026 Whitehawk Therapeutics has announced a major expansion of its antibody-drug conjugate (ADC) oncology pipeline...

GALWAY, Ireland, May 20, 2026 Medtronic plc has announced its intent to acquire SPR Therapeutics, Inc. in a deal...

YOKNEAM, Israel – May 8, 2026 Lumenis announced that its groundbreaking hair restoration platform FoLix™ has received the Hair...